Astrantus »

Merck & Co shares owned by Astrantus

Quarter-by-quarter ownership of Merck & Co (MRK) shares owned by Astrantus from 13F filings

Historical chart of Astrantus investment in Merck & Co

Tip: Access up to 7 years of quarterly data

All positions including Merck & Co held by Astrantus consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Merck & Co by Astrantus

Quarter filed Position value Share count Share price at filing
2022-03-31 $484k 5.9k 82.03
2021-12-31 $949k 12k 76.61

More positions owned by Astrantus

Visa Inc. Class A Cl A (V)
Vale (VALE)
Verizon Communications (VZ)
Merck & Co (MRK)
Novartis (NVS)
At&t (T)
Johnson & Johnson (JNJ)
Boston Scientific Corporation (BSX)
Unilever (UL)
Abbott Laboratories (ABT)
Apple (AAPL)
Bank of America Corporation (BAC)
Wells Fargo & Company (WFC)
Tor Dom Bk Cad (TD)
U.S. Bancorp (USB)

View all positions for Astrantus

Top funds holding Merck & Co

Vanguard Group
Wellington Management Company
Bank of America Corporation
Charles Schwab Investment Management
T. Rowe Price Associates
Norges Bank Investment Management
Jpmorgan Chase & Co
Legal & General Group
Deutsche Bank Aktiengesellschaft
Bank of New York Mellon
Wells Fargo & Company
Royal Bank of Canada
UBS Group
State Farm Mutual Automobile Insurance Company
Fisher Investments

View all funds holding Merck & Co